BACKGROUND: Percutaneous cholecystostomy (PC) can be used to treat patients with acute calculous cholecystitis (ACC) who are considered to be unfit for surgery. However, this procedure has been insufficiently investigated. This paper presents the results of a 10-year experience with this treatment modality. METHODS: A retrospective observational study of all consecutive patients treated with PC for ACC in the period from 1 May 2002 to 30 April 2012 was conducted. All data were collected from patients' medical records. RESULTS: A total of 278 patients were treated with PC for ACC. Of these, 13 (4.7%) died within 30 days, 28 (10.1%) underwent early laparoscopic cholecystectomy and three (1.1%) patients were lost from follow-up. Of the remaining 234 patients, 55 (23.5%) were readmitted for the recurrence of cholecystitis. In 128 (54.7%) patients, PC was the definitive treatment (median follow-up time: 5 years), whereas 51 (21.8%) patients were treated with elective laparoscopic cholecystectomy. The frequency of recurrence of cholecystitis in patients with contrast passage to the duodenum on cholangiography was lower than that in patients without contrast passage (21.1% versus 36.7%; P = 0.037). CONCLUSIONS: The present study, which is the largest ever conducted in this treatment area, supports the hypothesis that PC is an effective treatment modality for critically ill patients with ACC unfit for surgery and results in a low rate of 30-day mortality.
BACKGROUND: Percutaneous cholecystostomy (PC) can be used to treat patients with acute calculous cholecystitis (ACC) who are considered to be unfit for surgery. However, this procedure has been insufficiently investigated. This paper presents the results of a 10-year experience with this treatment modality. METHODS: A retrospective observational study of all consecutive patients treated with PC for ACC in the period from 1 May 2002 to 30 April 2012 was conducted. All data were collected from patients' medical records. RESULTS: A total of 278 patients were treated with PC for ACC. Of these, 13 (4.7%) died within 30 days, 28 (10.1%) underwent early laparoscopic cholecystectomy and three (1.1%) patients were lost from follow-up. Of the remaining 234 patients, 55 (23.5%) were readmitted for the recurrence of cholecystitis. In 128 (54.7%) patients, PC was the definitive treatment (median follow-up time: 5 years), whereas 51 (21.8%) patients were treated with elective laparoscopic cholecystectomy. The frequency of recurrence of cholecystitis in patients with contrast passage to the duodenum on cholangiography was lower than that in patients without contrast passage (21.1% versus 36.7%; P = 0.037). CONCLUSIONS: The present study, which is the largest ever conducted in this treatment area, supports the hypothesis that PC is an effective treatment modality for critically illpatients with ACC unfit for surgery and results in a low rate of 30-day mortality.
Authors: Nicole Cherng; Elan T Witkowski; Erica B Sneider; Jason T Wiseman; Joanne Lewis; Demetrius E M Litwin; Heena P Santry; Mitchell Cahan; Shimul A Shah Journal: J Am Coll Surg Date: 2011-12-21 Impact factor: 6.113
Authors: Ye Rim Chang; Young-Joon Ahn; Jin-Young Jang; Mee Joo Kang; Wooil Kwon; Woo Hyun Jung; Sun-Whe Kim Journal: Surgery Date: 2014-01-11 Impact factor: 3.982
Authors: E Atar; G N Bachar; S Berlin; C Neiman; E Bleich-Belenky; S Litvin; M Knihznik; A Belenky; E Ram Journal: Clin Radiol Date: 2014-03-01 Impact factor: 2.350
Authors: Kathleen B To; Jill R Cherry-Bukowiec; Michael J Englesbe; Michael N Terjimanian; Cai Shijie; Darrell A Campbell; Lena M Napolitano Journal: Surg Infect (Larchmt) Date: 2013-11-25 Impact factor: 2.150
Authors: Donna Marie L Alvino; Zhi Ven Fong; Colin J McCarthy; George Velmahos; Keith D Lillemoe; Peter R Mueller; Peter J Fagenholz Journal: J Gastrointest Surg Date: 2017-02-21 Impact factor: 3.452
Authors: Khang Wen Pang; Chun Han Nigel Tan; Stanley Loh; Kin Yong Stephen Chang; Shridhar Ganpathi Iyer; Krishnakumar Madhavan; Wei Chieh Alfred Kow Journal: World J Surg Date: 2016-11 Impact factor: 3.352
Authors: Charlotte S Loozen; Jelmer E Oor; Bert van Ramshorst; Hjalmar C van Santvoort; Djamila Boerma Journal: Surg Endosc Date: 2016-06-17 Impact factor: 4.584
Authors: Francisco Schlottmann; Charles Gaber; Paula D Strassle; Marco G Patti; Anthony G Charles Journal: J Gastrointest Surg Date: 2018-09-17 Impact factor: 3.452